Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain
- 29 July 2024
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 264 (2) , 132-147
Abstract
Brain metastases are one of the most serious clinical problems in breast cancer (BC) progression, associated with lower survival rates and a lack of effective therapies. Thus, to dissect the early stages of the brain metastatic process, we studied the impact of brain organotropic BC cells’ secretomes on the establishment of the brain pre‐metastatic niche (PMN). We found that BC cells with specific tropism to the brain caused significant blood–brain barrier (BBB) disruption, as well as microglial activation, in both in vitro and in vivo models. Further, we searched for a brain‐organotropic metastatic signature, as a promising source for the discovery of new biomarkers involved in brain metastatic progression. Of relevance, we identified VGF (nerve growth factor inducible) as a key mediator in this process, also impacting the BBB and microglial functions both in vitro and in vivo. In a series of human breast tumors, VGF was found to be expressed in both cancer cells and the adjacent stroma. Importantly, VGF‐positive tumors showed a significantly worse prognosis and were associated with HER2 (human epidermal growth factor receptor 2) overexpression and triple‐negative molecular signatures. Further clinical validation in primary tumors from metastatic BC cases showed a significant association between VGF and the brain metastatic location, clearly and significantly impacting on the prognosis of BC patients with brain metastasis. In conclusion, our study reveals a unique secretome signature for BC with a tropism for the brain, highlighting VGF as a crucial mediator in this process. Furthermore, its specific impact as a poor prognostic predictor for BC patients with brain metastasis opens new avenues to target VGF to control the progression of brain metastatic disease. © 2024 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- European Regional Development Fund (NORTE‐01‐0145‐FEDER‐072678 ‐ Consórcio PORTO.CCC)
- Rede Nacional de Espectrometria de Massa (ROTEIRO/0028/2013, LISBOA‐01‐0145‐FEDER‐022125)
This publication has 71 references indexed in Scilit:
- Tools for studying human microglia: In vitro and in vivo strategiesBrain, Behavior, and Immunity, 2022
- Changes in VGF and C3aR1 gene expression in human adipose tissue in obesityMolecular Biology Reports, 2020
- Mapping distribution of brain metastases: does the primary tumor matter?Journal of Neuro-Oncology, 2020
- Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21Cell Reports, 2019
- Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cellsCellular and Molecular Life Sciences, 2016
- Cancer Secretomes and Their Place in Supplementing Other Hallmarks of Cancer2014
- Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression ProfilingEndocrine Pathology, 2013
- P‐cadherin functional role is dependent on E‐cadherin cellular context: a proof of concept using the breast cancer modelThe Journal of Pathology, 2012
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011
- Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent wayGlia, 2010